Coloplast A/S (OTCMKTS:CLPBY) Issues Quarterly Earnings Results

Coloplast A/S (OTCMKTS:CLPBY) posted its earnings results on Tuesday. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10, Zacks reports. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%.

Coloplast A/S Price Performance

CLPBY stock opened at $6.58 on Tuesday. The stock has a 50-day moving average price of $6.23 and a two-hundred day moving average price of $6.68. Coloplast A/S has a 1 year low of $5.64 and a 1 year high of $10.03. The stock has a market cap of $14.83 billion, a PE ratio of 47.00, a price-to-earnings-growth ratio of 2.12 and a beta of 0.13. The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66.

Analyst Ratings Changes

Separately, Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold”.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.